INS and Insulin resistance: The hypoglycemic effect of SGLT2i without increasing insulin secretion may result in body weight loss, which improves inflammatory state and insulin resistance, and induces an amelioration of oxidative stress, glucose and lipid metabolism, and BP (Figure 1).